Skip to main content
SpringerLink
Log in

Trizyklische Antidepressiva zur Initialbehandlung einer depressiven Episode? Kontra

Tricyclic antidepressants for initial treatment of depressive episodes? Con

  • Pro und Kontra
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Adli M, Hegerl U (2014) Do we underestimate the benefits of antidepressants? Lancet 383(9926):1361–1362

    Article  PubMed  Google Scholar 

  2. American Psychiatric Association (APA) (2010) Work group on major depressive disorder. Practice guideline for the treatment of patients with major depressive disorder. (Third Edition). http://psychiatryonline.org/pb/assets/raw/ sitewide/practice_guidelines/guidelines/mdd. pdf. Zugegriffen: 11.10.2015

    Google Scholar 

  3. Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a Meta-analysis of efficacy and tolerability. J Affect Disord 58(1):19–36

    Article  CAS  PubMed  Google Scholar 

  4. Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, Matthews K, McAllister-Williams RH, Peveler RC, Scott J, Tylee A (2008) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 22(4):343–396

    Article  CAS  PubMed  Google Scholar 

  5. Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM (2007) WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Cochrane Database Syst Rev 18(3):CD002791

    Google Scholar 

  6. Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Möller HJ (2013) World Federation of Societies of Biological Psychiatry. Task Force on Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry 14(5):334–385

    Article  PubMed  Google Scholar 

  7. Bauer M, Monz BU, Montejo AL, Quail D, Dantchev N, Demyttenaere K, Garcia-Cebrian A, Grassi L, Perahia DG, Reed C, Tylee A (2008) Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry 23(1):66–73

    Article  PubMed  Google Scholar 

  8. DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (2009) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung. DGPPN, ÄZQ, AWMF, Berlin, Düsseldorf

    Google Scholar 

  9. DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (2015) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung. 2. Auflage, Konsultationsfassung – Stand: 20.07.2015. http://www.leitlinien.de/mdb/downloads/nvl/depression/depression-2aufl-konsultation.pdf. Zugegriffen: 11.10.2015

    Google Scholar 

  10. Gaebel W, Kowitz S, Fritze J, Zielasek J (2013) Inanspruchnahme des Versorgungssystems bei psychischen Erkrankungen. Sekundärdaten von drei gesetzlichen Krankenkassen und der Deutschen Rentenversicherung Bund. Dtsch Arztebl Int 110(47):799–808

    PubMed  PubMed Central  Google Scholar 

  11. Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J (2007) WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression. Cochrane Database Syst Rev 18(3):CD001851

    Google Scholar 

  12. Glassman AH, Walsh BT, Roose SP, Rosenfeld R, Bruno RL, Bigger JT Jr, Giardina EG (1982) Factors related to orthostatic hypotension associated with tricyclic antidepressants. J Clin Psychiatry 43(5 Pt 2):35–38

    CAS  PubMed  Google Scholar 

  13. Hotopf M, Hardy R, Lewis G (1997) Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. Br J Psychiatry 170:120–127

    Article  CAS  PubMed  Google Scholar 

  14. Knegtering HM, Huijsman E, Huijsman A (1994) Effects of antidepressants on cognitive functioning of elderly patients. A review. Drugs Aging 5(3):192–199

    Article  CAS  PubMed  Google Scholar 

  15. Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, Parikh SV, Patten SB, Ravindran AV (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT). Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord 117(Suppl 1):26–43

    Article  Google Scholar 

  16. Linde K, Kriston L, Rücker G, Jamil S, Schumann I, Meissner K, Sigterman K, Schneider A (2015) Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis. Ann Fam Med 13(1):69–79

    Article  PubMed  PubMed Central  Google Scholar 

  17. Luppa M, Sikorski C, Luck T et al (2012) Age- and gender-specific prevalence of depression in latest-life – systematic review and meta-analysis. J Affect Disord 136:212–221

    Article  CAS  PubMed  Google Scholar 

  18. National Institute for Health and Care Excellence (NICE) (2004) Depression: Management of depression in primary and secondary care. Clinical Guideline 23. https://www.nice.org.uk/guidance/cg23. Zugegriffen: 18.11.2015

    Google Scholar 

  19. Roose SP (2001) Depression, anxiety, and the cardiovascular system: the psychiatrist’s perspective. J Clin Psychiatry 62(Suppl 8):19–22

    PubMed  Google Scholar 

  20. Wissenschaftliches Institut der AOK (WIdO) (2014) Klauber, Günster, Gerste, Robra, Schmacke (Hrsg.). Versorgungs-Report 2013/2014. Schwerpunkt: Depression. Schattauer, Stuttgart

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Charité – Universitätsmedizin Berlin, Campus Mitte, Charitéplatz 1, 10117, Berlin, Deutschland

    M. Adli & M. Berger

  2. Ambulanz und Tagesklinik für Psychiatrie, Psychotherapie und Psychosomatik, Fliedner Klinik Berlin, Markgrafenstraße 34, 10117, Berlin, Deutschland

    M. Adli

Authors
  1. M. Adli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Berger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Adli.

Ethics declarations

Interessenkonflikt

M. Adli erhielt Honorare von Deutsche Bank, HRM Forum, Aristo, Merz, Gilead, ViiV, MSD, Berlin Chemie, BMS, mytomorrows, Servier und Lundbeck; Kongressunterstützungen/Reisekosten von Lundbeck sowie Forschungsgelder von Servier und Lundbeck.

M. Berger gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adli, M., Berger, M. Trizyklische Antidepressiva zur Initialbehandlung einer depressiven Episode? Kontra. Nervenarzt 87, 561–562 (2016). https://doi.org/10.1007/s00115-015-0032-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-015-0032-6

Search

Navigation